Health Sciences Public Relations and Marketing

Emmoe Marin and Alejandro Minera.

Keck Medicine of USC hosts health screenings at Festival of Books

Considered the largest public literary celebration in the country, the L.A. Times Festival of Books swept through the University Park Campus April 18 and 19.

Read The Full Story

Iroquois genes make cartilage cells act "oh so immature"

Arthritis, the leading cause of disability in the U.S., involves the loss of a special type of cartilage cell lining the joints. In a study appearing on the cover of the latest issue of Developmental Cell, first author Amjad Askary — a PhD student in the USC Stem Cell lab of Gage Crump — and his colleagues identify roles for a family of genes, called Iroquois (Irx) genes, in protecting these joint cartilage cells.

Read The Full Story

Q&A: USC Stem Cell Ambassador Richard Merkin

USC Stem Cell Ambassador Richard Merkin, MD, is the founder of the Heritage Provider Network, which, under his leadership, became the largest physician-owned and operated integrated delivery system in the United States. He sits on the boards of many colleges and universities, including the Board of Overseers at the Keck School of Medicine of USC, and is known as much for his philanthropy as for his leadership in the health care field. The Merkin Family Foundation recently established four assistant professorships in regenerative medicine at USC.

Read The Full Story

Ostrow awarded NIDCR grant to establish tissue regeneration center

Tissue regeneration is about to become more fact than fiction, thanks to a $2 million grant that’s being divided among 10 research centers and universities, including the Ostrow School of Dentistry of USC.

Read The Full Story

At Keck-Dornsife retreat, scientists share research

Seeking to strengthen partnerships between two of USC’s oldest schools, scientists from the Keck School of Medicine of USC and USC Dornsife College of Letters, Arts and Sciences recently gathered to discuss new research and areas for future collaboration.

Read The Full Story

USC Stem Cell researcher Min Yu receives the NIHs New Innovator Award

As a winner of the NIH Director’s New Innovator Award, USC Stem Cell principal investigator Min Yu will strive to develop individualized medicine targeting rare and deadly breast cancer stem cells. The five-year, $2.475 million award is part of the High-Risk, High-Reward Research program supported by the NIH Common Fund.

Read The Full Story
University of Southern California University of Southern California